Ultime notizie per Braskem (NYSE:BAK) Azioni

Braskem

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Braskem SA

Roadside Real Estate PLC

BakeryToken

Global Oil & Gas Ltd

Condor Energy Ltd

BAKER GLOBAL ASSET MGMT by Baker Global Asset Management Inc.

Baker Global Asset Management Inc

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul>
<li>On Nov. 11, UBS downgraded the stock from Buy to Neutral and lowered its price target from $161 to $97. The company's stock fell around 10% over the past month and has a <a href="https://www.benzinga.com/quote/CE">52-week low of $68.88</a>.</li>
<li>RSI Value: 25.90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CE Price Action: Shares of Celanese gained 1.6% to close at $70.54 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> latest CE news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png" alt="" class="wp-image-682682" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-768x702.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Dow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 3, Dow announced the appointment of Karen S. Carter as Chief Operating Officer. &#8220;Karen is a proven leader with more than three decades of experience at Dow delivering strong business results,&#8221; said Dow Chair and Chief Executive Officer Jim Fitterling. &#8220;She has an excellent track record of operating discipline, maintaining close relationships with key partners and customers, and driving innovation across the organization. She has successfully led our largest business and played critical leadership roles in other essential business and functional teams within Dow, always with a focus on developing and maintaining high-performing teams.&#8221; The company's stock fell around 9% over the past month and <a href="https://www.benzinga.com/quote/DOW">has a 52-week low </a>of $41.73.</li>
<li>RSI Value: 24.25</li>
<li>DOW Price Action: Shares of Dow fell 0.5% to close at $41.99 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> trend in DOW stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png" alt="" class="wp-image-682687" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-768x709.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">Braskem SA ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</h3>
<ul>
<li>On Sept. 18, UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10. The company's stock fell around 12% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/BAK">low of $4.68</a>.</li>
<li>RSI Value: 24.38</li>
<li>BAK Price Action: Shares of Braskem fell 5.8% to close at $4.82 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1">breakout in BAK shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="895" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png" alt="" class="wp-image-682689" style="width:583px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-768x719.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42380712/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Materials Stocks That May Rocket Higher In December

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Aspen Aerogels Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>)</h3>
<ul>
<li>On Nov. 6, Aspen Aerogels reported better-than-expected third-quarter revenue results.. The company's stock fell around 31% over the past month and has a 5<a href="https://www.benzinga.com/quote/ASPN">2-week low of $10.31</a>.</li>
<li>RSI Value: 26.83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ASPN Price Action: Shares of Aspen Aerogels rose 0.1% to close at $14.00 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">ASPN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071409/image-239.png" alt="" class="wp-image-660788" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071409/image-239.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071409/image-239-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071409/image-239-768x725.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">Braskem SA ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Sept. 18, UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10. The company's stock fell around 36% over the past month and<a href="https://www.benzinga.com/quote/bak"> has a 52-week</a> low of $64.98.</li>
<li>RSI Value: 18.13</li>
<li>BAK Price Action: Shares of Braskem fell 2.4% to close at $4.96 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">BAK stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071554/image-240.png" alt="" class="wp-image-660794" style="width:746px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071554/image-240.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071554/image-240-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071554/image-240-768x710.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">TMC the metals company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>)</h3>
<ul>
<li>On Nov. 14, TMC Metals posted third-quarter loss of 6 cents per share. Gerard Barron, Chairman &amp; CEO of The Metals Company commented, "This week we announced June 27, 2025, as the date for NORI to submit its exploitation application to the ISA. This decision, made in close consultation with NORI&#8217;s Sponsoring State Nauru, represents years of preparation, backed by the largest dataset ever collected on the deep sea in international waters. We&#8217;re excited to share our application with the ISA and stakeholders and recognize the responsibility that comes with submitting the world&#8217;s first application of this kind." The company's stock fell around 13% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/tmc">low of $0.80</a>.</li>
<li>RSI Value: 28.06</li>
<li>TMC Price Action: Shares of TMC the metals company fell 2.1% to close at $0.88 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1">breakout in TMC shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="878" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071859/image-241.png" alt="" class="wp-image-660802" style="width:718px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071859/image-241.png 878w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071859/image-241-300x289.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22071859/image-241-768x741.png 768w" sizes="(max-width: 878px) 100vw, 878px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42131399/dow-surges-over-450-points-investor-sentiment-improves-fear-greed-index-moves-to-greed-zone">Dow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To &#8216;Greed&#8217; Zone</a></li>
</ul>

ASPN

Top 3 Materials Stocks That Could Blast Off In November

Braskem's UTEC&#xAE; - Accelerating the Future of U.S. Lithium-Ion Battery Manufacturing
Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:<a href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>, LATIBEX: XBRK)), the Americas' leading polyolefins producer and a global pioneer in biopolymers, today proudly announces that the company has been selected by the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains to negotiate terms of a $50 million award under the Bipartisan Infrastructure Law. This landmark funding would expand Braskem's ultra-high molecular weight polyethylene (UHMWPE) production capabilities in La Porte, Texas, specifically targeting the lithium-ion battery separator (LIBS) market.

Contracts

Braskem Selected To Negotiate Terms Of A $50M Award From U.S. Department Of Energy To Drive Electrification Revolution

WIIM

Braskem shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10.

U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Wednesday.
Shares of Applied Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) rose sharply during Wednesday's session after the FDA communicated that an advisory committee meeting would <a href="https://www.benzinga.com/quote/APLT">no longer be required.</a>
Applied Therapeutics shares jumped 72% to $8.00 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares surged 52% to $8.19 after the company announced it was awarded a NASA Near Space Network contract for communication and navigation services, with a maximum potential value of $4.82 billion.</li>
<li>PowerFleet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) gained 13% to $5.26 after the company announced it entered into a definitive agreement for the acquisition of Fleet Complete for $200 million.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) surged 7.5% to $19.96.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) gained 7.5% to $7.43. UBS analyst Luiz Carvalho upgraded Braskem from Neutral to Buy and raised the price target from $7.7 to $10.</li>
<li>i-80 Gold Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#NASDAQ">IAUX</a>) jumped 7.5% to $1.15. The company announced the appointment of Richard Young as CEO.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>) gained 7% to $10.31.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) surged 6.9% to $19.67. Barclays analyst Adrienne Yih upgraded VF from Equal-Weight to Overweight and raised the price target from $19 to $22.</li>
<li>Gannett Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCI#NYSE">GCI</a>) gained 6.6% to $5.83.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) surged 6.1% to $14.89.</li>
<li>Victoria&#8217;s Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) rose 5.9% to $25.71. Barclays analyst Adrienne Yih upgraded Victoria&#8217;s Secret from Underweight to Equal-Weight and raised the price target from $23 to $25.  </li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) gained 4.6% to $117.55.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40917630/how-to-earn-500-a-month-from-darden-restaurants-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Darden Restaurants Stock Ahead Of Q1 Earnings</a></li>
</ul>

Intraday Update

Movers

AIOT

APLT

BLCO

GYRE

IAUX

LUNR

TERN

VSCO

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday

UBS analyst Luiz Carvalho upgrades Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) from Neutral to Buy and raises the price target from $7.7 to $10.

Upgrades

Price Target

Analyst Ratings

UBS Upgrades Braskem to Buy, Raises Price Target to $10

Braskem SA shares are trading lower after JP Morgan lowered its price target on the stock from $10 to $9.5.

JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) with a Neutral and lowers the price target from $10 to $9.5.

JP Morgan Maintains Neutral on Braskem, Lowers Price Target to $9.5

Citigroup analyst Gabriel Barra upgrades Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) from Neutral to Buy.

Citigroup Upgrades Braskem to Buy

JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) with a Neutral and lowers the price target from $11 to $10.

JP Morgan Maintains Neutral on Braskem, Lowers Price Target to $10

Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) reported $3.618 billion in sales this quarter. This is a 3.34 percent decrease over sales of $3.743 billion the same period last year.

Earnings

Braskem Q1 Sales $3.618B Down From $3.743B YoY, Net Loss $273M Down From Net Income $35M YoY

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.
Shares of Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) fell sharply during Monday's session as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion. Adjusted EPS loss was $(1.46), down from $(0.82), <a href="https://www.benzinga.com/quote/SAVE/earnings">missing the consensus of $(1.45).</a>
Spirit Airlines shares dipped 9.8% to $3.3450 on Monday.
Here are some other big stocks recording losses in today's session.
<ul>
<li>EyePoint Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) shares fell 37.7% to $12.29 after the company&#8217;s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.</li>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares tumbled 17.8% to $23.76 following weak second-quarter EPS guidance.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) declined 16.7% to $10.40 in pre-market trading after posting weaker-than-expected quarterly results.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) shares dipped 15.5% to $7.63 in pre-market trading after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) declined 15.2% to $13.97 after the stock rose more than 40% last week.</li>
<li>Uniti Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) declined 11.5% to $3.9489 after the company announced plans for a $300 million offering of 10.50% Senior Secured Notes due 2028 by its subsidiaries.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) tumbled 10.3% to $33.41 after the company reported mixed first-quarter financial results including a net sales decline.</li>
<li>Jasper Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) dipped 9.2% to $22.28. HC Wainwright &amp; Co. analyst Emily Bodnar initiated coverage on Jasper Therapeutics with a Buy rating and announced a price target of $65.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) declined 7.9% to $9.18.</li>
<li>Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) declined 8% to $4.48 after tenant Steward Health Care reportedly filed for bankruptcy protection.</li>
<li>Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) fell 7.8% to $57.18 following weak quarterly sales.</li>
<li>Allego N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLG#NASDAQ">ALLG</a>) declined 7.8% to $1.1799.</li>
<li>CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) fell 7.1% to $2.9080.</li>
<li>Titan International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) declined 6.7% to $9.36.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) fell 3.8% to $3.78.</li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) fell 3.8% to $299.53.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38646096/bitcoin-ethereum-move-lower-akash-network-becomes-top-loser">Bitcoin, Ethereum Move Lower; Akash Network Becomes Top Loser</a>

ALLG

AMGN

BOWL

CRML

CVAC

EYPT

GERN

IART

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

SAVE

UNIT

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday

Shares of Perficient, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFT#NASDAQ">PRFT</a>) shares rose sharply during Monday's session after the company disclosed an acquisition deal and <a href="https://www.benzinga.com/quote/PRFT/earnings">first-quarter FY24 results</a>.
The company stated that it has entered into a definitive deal to be acquired by an affiliate of BPEA Private Equity Fund VIII (EQT Asia), part of EQT AB in an all-cash transaction at an enterprise value of around $3.0 billion.
Perficient shares jumped 53% to $73.60 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) gained 19% to $5.30 following strong first-quarter results.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 15% to $2.1050.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) gained 13.2% to $19.83.</li>
<li>Trupanion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) rose 10.9% to $22.02. The company recently reported first-quarter financial results.</li>
<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) surged 10.9% to $1.4750. Ocugen is expected to host conference call on Tuesday, May 14 to discuss business updates and first quarter 2024 financial results.</li>
<li>SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares gained 10.5% to $2.5999.</li>
<li>SelectQuote, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) jumped 10.3% to $2.25. SelectQuote is expected to Release fiscal third quarter 2024 earnings on May 9.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) gained 9.4% to $7.80.</li>
<li>Atlas Energy Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NASDAQ">AESI</a>) rose 7.7% to $23.65, reversing from earlier weakness after reporting first-quarter results. The company also raised its dividend.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>EyePoint Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) dipped 37.7% to $12.29 after the company&#8217;s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.</li>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares dropped 17.8% to $23.76 following weak second-quarter EPS guidance.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) fell 16.7% to $10.40 in pre-market trading after posting weaker-than-expected quarterly results.</li>
<li>Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) shares declined 15.5% to $7.63 in pre-market trading after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell 15.2% to $13.97 after the stock rose more than 40% last week.</li>
<li>Uniti Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) fell 11.5% to $3.9489 after the company announced plans for a $300 million offering of 10.50% Senior Secured Notes due 2028 by its subsidiaries.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) dipped 10.3% to $33.41 after the company reported mixed first-quarter financial results including a net sales decline.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) declined 9.8% to $3.3450 as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) fell 7.9% to $9.18.</li>
<li>Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) fell 7.8% to $57.18 following weak quarterly sales.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38641042/how-to-earn-500-a-month-from-fmc-stock-ahead-of-q1-earnings">How To Earn $500 A Month From FMC Stock Ahead Of Q1 Earnings</a>

AESI

BCRX

MARA

OCGN

PACB

PRFT

SLQT

SNDL

TRUP

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session

Braskem shares are trading lower after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.

The performance of the U.S. corporate bond market in the first quarter of the year was generally flat, though there were notable distinctions between the high-grade <a href="https://www.benzinga.com/money/high-yield-bonds">and high-yield sectors. </a>
Bonds issued by companies with higher credit ratings (BBB and above) experienced a slight downward trajectory, as showed by the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>). Conversely, lower-rated companies boasting higher yields showed modestly positive performance, as indicated by the iShares iBoxx $ High Yield Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYG#NYSE">HYG</a>).
Also Read: <a href="https://www.benzinga.com/news/large-cap/24/04/38098774/top-10-us-high-yield-corporate-bonds-with-returns-over-20-in-april-2024">Top 10 US High-Yield Corporate Bonds With Returns Over 20% In April 2024</a>
Below is a list of U.S. corporate bonds that have exhibited the strongest performance in the last three months.
<h3 class="wp-block-heading">10) Macy&#8217;s Retail Holdings LLC 4.3% 12/43</h3>
<ul>
<li>Issuer: Macy&#8217;s Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 15.83%</li>
</ul>
<h3 class="wp-block-heading">9) Ally Financial Inc. 4.7%</h3>
<ul>
<li>Issuer: Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>)</li>
<li>ISIN: US02005NBN93</li>
<li>Last price: $78.174</li>
<li>Type: subordinated</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 16.91%</li>
</ul>
<h3 class="wp-block-heading">8) Lincoln National Corp. 7.938% 06/66</h3>
<ul>
<li>Issuer: Lincoln National Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>)</li>
<li>ISIN: US534187AS84</li>
<li>Last price: $74.73</li>
<li>Maturity: 17/05/2066</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 17.87%</li>
</ul>
<h3 class="wp-block-heading">7) Carvana Co. 5.875% 20/28</h3>
<ul>
<li>Issuer: Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)</li>
<li>ISIN: USU1468GAD61</li>
<li>Last price: $65.00</li>
<li>Yield to maturity (%): 18.1963</li>
<li>Maturity: 01/10/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 20.37%</li>
</ul>
<h3 class="wp-block-heading">6) Braskem America Finance Co. 7.125% 11/41</h3>
<ul>
<li>Issuer: Braskem S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</li>
<li>ISIN: USU1065PAA94</li>
<li>Last price: $90.85</li>
<li>Yield to maturity (%): 8.2834</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $200,000</li>
<li>3-month performance: 20.5%</li>
</ul>
<h3 class="wp-block-heading">5) M.D.C. Holdings Inc. 3.966% 21/61</h3>
<ul>
<li>Issuer: M.D.C. Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDC#NYSE">MDC</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 23.53%</li>
</ul>
<h3 class="wp-block-heading">4) QVC Inc. 5.95% 13/43</h3>
<ul>
<li>Issuer: QVC Inc.</li>
<li>ISIN: US747262AM52</li>
<li>Last price: $64.53</li>
<li>Yield to maturity (%): 10.4849</li>
<li>Maturity: 15/03/2043</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 23.76%</li>
</ul>
<h3 class="wp-block-heading">3) At Home Group Inc. 4.875% 21/28</h3>
<ul>
<li>Issuer: At Home Group Inc.</li>
<li>ISIN: USU04798AA90</li>
<li>Last price: $47.61</li>
<li>Yield to maturity (%): 27.4573</li>
<li>Maturity: 15/07/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 26.38%</li>
</ul>
<h3 class="wp-block-heading">2) Lumen Technologies Inc. 4.5% 20/29</h3>
<ul>
<li>Issuer: Lumen Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>)</li>
<li>ISIN: USU1566PAD79</li>
<li>Last price: $36.32</li>
<li>Yield to maturity (%): 33.1453</li>
<li>Maturity: 15/01/2029</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 27.01%</li>
</ul>
<h2 class="wp-block-heading">Chart: Lumen Technologies Bond Outperforms Lumen Shares In 2024</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png" alt="" class="wp-image-277973" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">1) Beyond Meat Inc. 0.000% 21/27</h3>
<ul>
<li>Issuer: Beyond Meat Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>)</li>
<li>ISIN: US08862EAB56</li>
<li>Last price: $23.87</li>
<li>Maturity: 15/03/2027</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 28.08%</li>
</ul>
<h2 class="wp-block-heading">Chart: Beyond Meat Bonds Outperform Shares In 2024</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png" alt="" class="wp-image-277986" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Why Have Beyond Meat Bonds Outperformed Shares?</h2>
Beyond Meat reported higher than expected revenue in the fourth quarter of 2023, yet suffered larger losses than anticipated. Following the earnings announcement, the company committed to significantly cutting costs and enhancing manufacturing efficiency. 
These efforts improved the outlook on the company&#8217;s ability to fulfill its debt obligations, boosting investor confidence in Beyond Meat&#8217;s survival prospects, rather than reflecting a true turnaround in its long-term profitability.
Following its earnings report, Beyond Meat saw an initial market enthusiasm with rises in both bonds and shares. However, while bond values maintained their upward trajectory, the stock&#8217;s gains quickly dissipated, reversing the post-earnings uplift. 
Since the beginning of the year, Beyond Meat&#8217;s zero-coupon bond, due to mature in March 2027, has seen a notable increase of 28%, contrasting with a roughly 6% drop in the company&#8217;s share price.
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38091433/ai-revolution-is-underway-yet-its-economic-impact-is-several-years-off-goldman-sach">AI Revolution Is Underway, Yet Its Economic Impact Is &#8216;Several Years Off&#8217;: Goldman Sachs</a>
Image generated using artificial intelligence via Midjourney.

Fintech news covering the emerging Financial Technology services sector

Fintech

Large Cap

Mid Cap

Bonds

Specialty ETFs

Small Cap

ETFs

ALLY

BYND

CVNA

LUMN

Top 10 US Corporate Bonds By Market Performance In 2024: April Update

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.
Shares of Sportradar Group AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srad#NASDAQ">SRAD</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million <a href="https://www.benzinga.com/quote/SRAD/earnings">share repurchase program</a>.
Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company&rsquo;s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sportradar Group shares jumped 10.7% to $11.17 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Annovis Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NASDAQ">ANVS</a>) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer&#39;s disease, with Topline efficacy data expected in April.</li>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) gained 23% to $2.7650 after the company reported a year-over-year increase in FY23 EPS results.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) climbed 18.1% to $43.00.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 18% to $2.0297 amid a rise in Bitcoin.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) jumped 16.7% to $3.7600 after the company reported a fourth-quarter fiscal 2023 revenue of $242.6 million, marginally beating the consensus of $242.4 million.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) climbed 16.5% to $31.70.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) climbed 12.7% to $10.13 after the company on Tuesday reported fourth-quarter financial results.</li>
<li>LiveWire Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lvwr#NYSE">LVWR</a>) surged 12.5% to $7.29.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) gained 12.4% to $10.25.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) climbed 12.3% to $56.55 after the company announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation achieved a &#39;positive predictive outcome&#39; and will conclude enrollment earlier than anticipated.</li>
<li>Topgolf Callaway Brands Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modg#NYSE">MODG</a>) rose 11.8% to $16.11 following a Chosun Daily report suggesting the company is up for sale.</li>
<li>Alight, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alit#NASDAQ">ALIT</a>) gained 11.5% to $9.85 after the company announced an agreement to sell its Payroll &amp; Professional Services business for up to $1.2 billion.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 10.5% to $6.00.</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) climbed 9.3% to $4.3050.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) rose 7.5% to $17.72.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 7.5% to $20.77 amid a rise in Bitcoin.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) climbed 6.8% to $23.92.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) rose 6.7% to $35.19.</li>
<li>Carvana Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) climbed 5.3% to $83.07.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmg#NYSE">CMG</a>) gained 5.1% to $2,941.41 after company&#39;s board approved a 50-for-1 split of common shares.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37839587/disney-jpmorgan-and-more-cnbcs-final-trades"> Disney, JPMorgan And More: CNBC&#39;s &#39;Final Trades&#39;</a>

Penny Stocks

ALIT

ANVS

CLSK

DRCT

DWAC

IBRX

LIVN

LVWR

MODG

SKIN

SRAD

TSHA

WULF

Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday

Braskem shares are trading higher after the company on Tuesday reported Q4 financial results.

Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) reported its Q4 earnings results on Tuesday, March 19, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Braskem missed estimated earnings by -45.0%, reporting an EPS of $-0.8 versus an estimate of $-0.55.
Revenue was down $244.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.2 which was followed by a 0.0% increase in the share price the next day.

To track all earnings releases for Braskem <a href="https://www.benzinga.com/quote/BAK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Braskem Q4 Earnings

Braskem shares are trading higher after the company reported Q4 financial results.

BRASKEM S.A.&nbsp;((B3: BRKM3, BRKM5 and BRKM6, NYSE:<a href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>, LATIBEX: XBRK)) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 4Q23 Earnings Release.
4Q23 HIGHLIGHTS&nbsp;
CONSOLIDATED
<ul>
<li>Recurring EBITDA of US$ 211 MM, around R$1,049 million. Higher than 3Q23 (+US$23 million) and 4Q22 (+US$243 million).</li>
<li>Cash position&nbsp;of US$ 3.6 billion, ensuring coverage of debt maturities over the next 72 months.</li>
<li>Cost reduction: Reduction of ~23% in general and administrative expenses, compared to 4Q22. Approximately R$186 MM as a result of fixed cost reduction initiatives.</li>
<li>PE Production – Mexico: Utilization Rate of 84%, +18 p.p. vs. 3Q23 and +15 p.p. vs. 4Q22. Consistent feedstock supply.</li>
</ul>
The full earnings release is available on the Company's IR website: <a href="http://www.braskem-ri.com.br/en">www.braskem-ri.com.br/en</a>
Braskem will host conference calls to discuss its Results Tuesday, March 19 at 11:00 a.m. US ET.

Braskem Posts Q4 Recurring EBITDA Of $211M, Up 13% From QoQ; Cash Position Of $3.6B, Ensuring Coverage Of Debt Maturities Over The Next 72 Months

Press Releases

Braskem Expands Its Fuels Business Portfolio With the Launch of Octane Plus

Commodities

Braskem posts Recurring EBITDA of US$320 million in the quarter, 39% higher than 1Q24 and 128% higher than 2Q23

Braskem and WEAV3D® Win the Altair Enlighten 2024 Future of Lightweighting Award

Braskem Announces the Official Opening of its Renewable Innovation Center in Lexington, Massachusetts

Braskem America Introduces Bio-Circular Polypropylene (PP): A Sustainable Solution for the Restaurant and Snack Food Industries

Braskem Selected to Negotiate Terms of a Prestigious $50 Million Award from U.S. Department of Energy to Drive Electrification Revolution

Braskem and WEAV3D® Awarded by the Society for Plastics Engineers (SPE) and American Composites Manufacturers Association (ACMA)

Braskem reports Recurring EBITDA of R$2.4 billion in 3Q24, 44% higher compared to 2Q24

Philadelphia Eagles and Braskem "Tackling STEM" Program Empowers Youth Across the Greater Philadelphia Area

Braskem reports Recurrent Cash Generation of R$265 million in 4Q24; Recurring EBITDA of US$1.1 billion in 2024 (46% higher than 2023)

AdvanSix

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

Gulf Resources

Hawkins

Koppers Holdings

Kronos Worldwide

Loop Industries

Mativ Holdings

Orion

Olin

Origin Materials, Inc. - Class A Common Stock

Origin Materials

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Tantech Hldgs

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical

JP Morgan

Scotiabank

Comments

Braskem

Notizie

Ultime notizie per Braskem (NYSE:BAK) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO